Total submissions: 2
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Invitae | RCV002620854 | SCV003511020 | likely pathogenic | not provided | 2023-09-24 | criteria provided, single submitter | clinical testing | This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 2520 of the CDH23 protein (p.Glu2520Lys). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with CDH23-related conditions (PMID: 32467589; Invitae). ClinVar contains an entry for this variant (Variation ID: 2191926). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on CDH23 protein function. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. |
| Baylor Genetics | RCV003475515 | SCV004212344 | likely pathogenic | Pituitary adenoma 5, multiple types | 2023-01-10 | criteria provided, single submitter | clinical testing |